BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections

  August 28, 2024

   · 

  5 min read
• Press Releases

  Chemomab Therapeutics to Present at September 2024 Investor Conferences

  August 28, 2024

   · 

  2 min read
• Press Releases

  Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)

  August 28, 2024

   · 

  10 min read
• Press Releases

  Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer

  August 28, 2024

   · 

  7 min read
• Press Releases

  Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1117568 in Adults with Schizophrenia

  August 28, 2024

   · 

  9 min read
• Press Releases

  I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates

  August 28, 2024

   · 

  26 min read
• Press Releases

  AKTIS ONCOLOGY TO PARTICIPATE IN THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

  August 28, 2024

   · 

  1 min read
• Press Releases

  Formedics Acquires AMC Media Group Amplifying Its Content and Peer-to-Peer HCP Community

  August 28, 2024

   · 

  4 min read
• Press Releases

  BridgeBio Pharma to Participate in September Investor Events

  August 28, 2024

   · 

  1 min read
• Press Releases

  FDA Confirms Acceptability of Palatin’s Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye Disease (DED)

  August 28, 2024

   · 

  6 min read